New: NCI-funded clinical trial search
Mednet Logo
SpecialtiesNephrology
Nephrology

Nephrology

Clinical discussions on kidney disease management, dialysis, transplantation, and electrolyte disorders.

Recent Discussions

What factors do you consider when deciding to treat IgA nephropathy with immunosuppression in a patient with cirrhosis, given the possibility that IgA nephropathy could be secondary to cirrhosis?

1
5 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

Proteinuria is the most important factor here. If there is significant proteinuria (>1 g/d) and no other clear reason for it, I would treat the IgA nephropathy with immunosuppression. Secondary IgA due to cirrhosis is usually not associated with significant proteinuria.

How would you approach a patient with class III and V lupus nephritis, already on HCQ, MMF, voclosporin and losartan, but has continued proteinuria not yet attaining complete renal response?

7
4 Answers

Mednet Member
Mednet Member
Nephrology · Rush Medical College

Few things are more complicated than lupus nephritis, and this question is not answered easily. It depends on hematuria, Cr, proteinuria, C3, C4, dsDNA, and systemic symptoms. So, it depends on what I think is causing the incomplete clinical response. If I believe it is the class V lesion, I would g...

Do you recommend a metabolic evaluation in a kidney transplant patient with no prior history of nephrolithiasis who is found to have donor derived kidney stones?

1
1 Answers

Mednet Member
Mednet Member
Nephrology · Mayo Clinic

Thanks for an interesting question. It would help if we knew the relevant donor medical history, such as dietary indiscretions or enteric hyperoxalutia, which would not be issues in the recipient. Since this information is typically not available, I would collect two 24-hour urinary supersaturation ...

How do you approach the use of genetic testing in patients older than 30 years with resistant hypertension and hypokalemia, but with a normal aldosterone to renin ratio and no known family history of hypertension?

1 Answers

Mednet Member
Mednet Member
Nephrology · Boston University Chobanian & Avedisian School of Medicine

I am starting to use genetic testing more frequently now on patients like this, even though the absence of family history makes monogenic HTN less likely. Once other causes of hypertension with hypokalemia (Cushing syndrome, ectopic ACTH, licorice, etc.) are excluded, I think genetic testing may hel...

What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?

4 Answers

Mednet Member
Mednet Member
Hospital Medicine · Icahn School of Medicine at Mount Sinai

First, it's important to remember that most of us have inconsistent beliefs. We both want to lose weight, and we want to eat chocolate cake; we want to get an A, and we want to go to the party. So when we see inconsistencies in others' beliefs, rather than being judgmental, we should get curious. Ou...

Do you postpone hemodialysis for a period of time after stem cell transplantation in a hospitalized patient with ESKD?

2 Answers

Mednet Member
Mednet Member
Nephrology · Memorial Sloan Kettering Cancer Center

No. In fact, some patients may require extra HD sessions to manage volume overload post SCT. All ESKD patients are assessed daily for HD and continue to receive thrice-weekly dialysis per routine. If they are persistently hypotensive, they are considered for transition to CRRT.

In a patient with high +SSA antibodies and distal renal tubular acidosis (RTA), but without sicca symptoms or other systemic features of Sjogren's, should immunomodulatory therapy with hydroxychloroquine or azathioprine be considered in an effort to reduce subclinical tubular inflammation and prevent progression of renal disease?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

Renal disease can occur as an initial manifestation in the absence of sicca in SjÓ§gren’s disease (SjD) patients (Goules et al., PMID 31464673). This is important to realize for other systemic manifestations of SjD (e.g., cystic lung disease, tubulointerstitial nephritis, radiographic nephrocalcino...

Would you start sodium citrate for patients with advanced chronic kidney disease and metabolic acidosis who fail to reach serum bicarbonate target despite high doses of sodium bicarbonate?

2 Answers

Mednet Member
Mednet Member
Nephrology · University Of California San Francisco Medical Center At Parnassus

I don't think sodium citrate is any more effective than sodium bicarbonate in improving metabolic acidosis. Sodium bicarbonate is more likely to cause gastric distention and air. If that results in noncompliance, then it is worth switching. It is also important these patients are on diuretic as much...

Are you comfortable using low molecular weight heparin as an alternative to unfractionated heparin for ESKD patients on nocturnal home hemodialysis?

1 Answers

Mednet Member
Mednet Member
Nephrology · UCLA

Low molecular weight heparin may be used as an alternative to unfractionated heparin for ESKD patients on nocturnal home hemodialysis. However, its use requires close monitoring and careful management. Unlike unfractionated heparin, which is fully reversible with protamine, LMWH is only partially re...

Would you pursue a kidney biopsy in a patient with stable stage 1 AKI, bland urine sediment, and a positive MPO titer without systemic signs of vasculitis?

2
2 Answers

Mednet Member
Mednet Member
Nephrology · Loyola University Health System

PR3-ANCA and MPO-ANCA are associated with substantially higher specificities and positive predictive values for ANCA-associated vasculitis (AAV) than the immunofluorescence patterns to which they usually correspond (C-ANCA and P-ANCA, respectively). However, false-positive results remain a concern. ...